investingreview.org logo
Avoid Fraud, Get The Facts, And Find The Best
Nothings Found.

The Rise and Fall of Strategic Point Investment Advisors, LLC’s Q4 2022 vs. Q1 2023: An Honest Comparison

Ava Hoppe | 11 May, 2023

Strategic Point Investment Advisors, LLC is known for its substantial holdings in various exchange-traded funds (ETFs) and stocks. The company would file a quarterly report, Form 13F, to the Securities and Exchange Commission (SEC) disclosing their holdings’ value and changes every quarter. 

Looking at the Q4 2022 vs. Q1 2023 comparison of their 13F holdings, we can see quite a few changes in their investments. In this article, we will analyze the changes in the value and percentage of shares held in different companies to help you understand the current scenario of Strategic Point Investment Advisors, LLC.

Let's start by examining the most substantial fall of 61.1% in the Ishares TR qualifier (QUAL). The company's percentage of shares fell from 180,605 to 64,512, making it the most significant fall in Q1 2023. QUAL is one of the popular ETFs known for its equity exposure to the U.S. market's high-quality stocks.

Moving on to the second-largest fall, we have the Ishares TR - Growth Style ETF (IWF). It recorded a fall of 34.7% with shares dropping from 47,045 to 26,935. In contrast, the value slipped from $10,079,000 to $6,580,000 in Q1 2023. The fund targets companies exhibiting high growth characteristics, mainly in the technology and healthcare sectors.

Another noticeable decline is seen in the Vanguard World FDS (VHT), where Strategic Point Investment Advisors, LLC's shares slipped from 57,089 to 56,789. As a result, the company's percent change plunged by 4.4% to $13,541,000 from $14,161,000 in Q4 2022. The fund aims to provide exposure to the entire spectrum of the health care industry, including biotechnology, pharmaceuticals, and medical devices.

But it was not all downhill for the New York-based investment advisor. The Listed FD TR (CCOR) showed growth of 42.4% with shares rising from 611,742 to 922,356, indicating the company's renewed focus on diversifying its portfolio. The fund primarily invests in investment-grade corporate bonds, selected based on their fundamental value and growth potential. The overall value of its investment in Q1 2023 increased by 42.4% to $27,513,000 from $19,319,000.

The employer-sponsored insurance industry is also making a significant comeback from the pandemic; hence, the Ishares TR - MSCI USA ESG Optimized ETF (ESGV)  stands out. The Company increased its holdings in the MSCI USA ESG Optimized ETF by 10.7%, with shares rising from 11,105 to 11,280. As a result, the funds' value increased by 10.7% to $808,000 from $731,000 in Q1 2023.

As expected, some companies maintain their position and show a minimal percentage change. The Select Sector SPDR TR-Industrial ETF (XLI) holds a total of 117,809 and 117,584 shares in Q4 2022 and Q1 2023, respectively, with only a 2.8% change.

In conclusion, Strategic Point Investment Advisors, LLC's recent quarterly report, Q1 2023, shows that the company is making strategic adjustments to its portfolio. They have sold off certain funds such as the ISHARES TR and re-invested the proceeds in others such as the Ishares TR - MSCI USA ESG Optimized ETF (ESGV). This type of analysis allows potential investors and investment professionals to examine a company's asset allocation strategy for Q1 2023, allowing them to make informed investment decisions.

Many people have been burned by frauds and Ponzi schemes. So we created this website to help you, the potential investor, get the facts, find the best, and avoid fraud and Ponzi schemes.

All information provided on this website is provided without warranty and for informational purposes only.
InvestingReview.org does not provide investment advice. InvestingReview.org is not an investment adviser and is not endorsed by or affiliated with any U.S. or non-U.S. regulatory agency.


Recently Searched Firms

Please note: Search data is accumulated by 3rd party and refreshed once per day.

Copyright © 2023 by InvestingReview.org / All Rights Reserved.